Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 3 15Phase NA 8Phase 1 6Phase 1/2 3Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 9Active not recruiting 3Withdrawn 2Recruiting 2Unknown 1Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Multiple Myeloma 26Breast Neoplasms 21Colorectal Neoplasms 17Neoplasms 15Lymphoma, B-Cell 15Prostatic Neoplasms 14Stomach Neoplasms 12Carcinoma, Hepatocellular 12Recurrence 11Lung Neoplasms 11Burkitt Lymphoma 11Solid Tumor 10Pancreatic Neoplasms 10Leukemia, Myeloid, Acute 10Carcinoma, Non-Small-Cell Lung 10Uterine Cervical Neoplasms 9Lymphoma, Non-Hodgkin 9Glioblastoma 9Leukemia 8Ovarian Neoplasms 7Sarcoma 6Polycystic Ovary Syndrome 6Glioma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma 5Hematologic Neoplasms 5Head and Neck Neoplasms 5Neuroendocrine Tumors 4Lymphoma, T-Cell, Peripheral 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Unknown × Fallopian Tube Neoplasms × Clear all
NCT05801783 2023-04-06

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer

Shanghai Yunying Medical Technology

Phase EARLY_PHASE1 Unknown
10 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡